「Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation」の関連論文
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
-
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
Comparison of robot-assisted partial nephrectomy for complex (RENAL scores >= 10) and non-complex renal tumors: A single-center experience
-
Survival Analyses Based on Tumor Microenvironment Profile in Endometrial Carcinoma
-
Functional and genomic characterization of patient-derived xenograft model to study adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
-
Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
A novel urinary microRNA biomarker panel for detecting gastric cancer
-
Real-life progression of the use of a genetic panel in to diagnose neonatal cholestasis
-
Prognostic nutritional index of early post-pembrolizumab therapy predicts long-term survival in patients with advanced urothelial carcinoma
-
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function
-
Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas.
-
卵巣低異型度漿液性癌のin vitro発癌モデル
-
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
-
Comparison of cytoreductive surgery and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer: a retrospective study
-
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
-
PBK expression predicts favorable survival in colorectal cancer patients
-
Low RAI2 expression is a marker of poor prognosis in breast cancer
-
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review
-
RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence
-
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
-
Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma (本文)
-
Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis
-
Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal
-
An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
-
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
-
Evaluating the effect of lenvatinib on sorafenib-resistant hepatocellular carcinoma cells
-
Diagnostic value of PET/CT with ¹¹C-methionine (MET) and ¹⁸F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
-
Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor
-
How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement
-
Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung
-
Clinicopathologic factors associated with tumor necrosis after preoperative embolization of meningiomas
-
Early Alteration in Apparent Diffusion Coefficient and Tumor Volume in Cervical Cancer Treated with Chemoradiotherapy or Radiotherapy: Incremental Prognostic Value over Pretreatment Assessments
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
The Advantages of Robotic Gastrectomy over Laparoscopic Surgery for Gastric Cancer
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
FE65 in breast cancer: its clinicopathological and biological significance
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
Multicenter retrospective study of the prognosis and the effect of postoperative adjuvant therapy in Japanese oral squamous cell carcinoma patients with close margin
-
Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
-
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients
-
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer.
-
Systemic therapy for salivary gland malignancy: current status and future perspectives